Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Jul 20;18:3989–4005. doi: 10.2147/IJN.S417445

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2023 Yang et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

The anti-tumor efficiency of different groups in vivo. (A) The photograph of excised tumors on day 25 post-treatment. (B) Tumor weight of excised tumors. A significant difference was observed in the Tamhane’s T2 test. (C) Tumor growth curves of the mice during treatments. A significant difference was observed in the median test. (D) Body weight changes curves of the mice during treatments. A significant difference was observed in the LSD post-hoc test. (E) Survival curves of mice in different groups. A significant difference was observed in the log-rank survival analysis. ***P < 0.001, **P < 0.01, *P < 0.05.